NasdaqGM - Nasdaq Real Time Price USD

Alpha Teknova, Inc. (TKNO)

6.72

+0.18

+(2.75%)

At close: May 20 at 4:00:00 PM EDT

Sidoti Events, LLC's Virtual May Micro-Cap Conference

NEW YORK, NY / ACCESS Newswire / May 20, 2025 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day May Micro-Cap Conference taking place Wednesday and Thursday, May 21-22, ...

ACCESS Newswire 20 hours ago

LFWD

CMCXF

HFFG
Alpha Teknova Inc (TKNO) Q1 2025 Earnings Call Highlights: Revenue Growth Amidst Challenges

Alpha Teknova Inc (TKNO) reports a 5% revenue increase and improved gross margins, despite facing declines in clinical solutions and custom product sales.

GuruFocus.com 12 days ago

TKNO
+2.75%
Alpha Teknova: Q1 Earnings Snapshot

TKNO) on Thursday reported a loss of $4.6 million in its first quarter. On a per-share basis, the Hollister, California-based company said it had a loss of 9 cents. The maker of reagents used by the biopharmaceutical industry posted revenue of $9.8 million in the period.

Associated Press Finance 12 days ago

TKNO
+2.75%
Teknova Reports First Quarter 2025 Financial Results

First quarter 2025 total revenue was $9.8 million, up 5% from prior yearCompany introduced proprietary PluriFreeze™ cryopreservation system, in collaboration with Pluristyx, Inc.Company reaffirms 2025 revenue guidance of $39-42 million HOLLISTER, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova” or the “Company”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnosti

GlobeNewswire 12 days ago

TKNO
+2.75%
Alpha Teknova (TKNO) Traded Lower on Increased Uncertainty

Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equity markets started the year with a rally due to optimism about a strong economy and expectations of moderating inflation and lower interest rates. However, concerns over slowing earnings from major Technology companies, geopolitical […]

Insider Monkey 20 days ago

TKNO
+2.75%

^RUT
Teknova to Report First Quarter 2025 Financial Results on May 8, 2025

HOLLISTER, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the first quarter ended March 31, 2025, on Thursday, May 8, 2025, following the close of market. Teknova will host a webcast and conference call on Thursday, May 8, 2025, begin

GlobeNewswire 26 days ago

TKNO
+2.75%
Teknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell Therapies

Innovative product line is purpose-built to streamline the manufacture of allogeneic cell therapies. Available exclusively from Teknova starting today.HOLLISTER, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), and Pluristyx, Inc., today announced that Pluristyx’s PluriFreeze™ cryopreservation system is available for purchase exclusively from Teknova. Teknova is a leading producer of critical reagents for the discovery, development, and commercialization

GlobeNewswire 2 months ago

TKNO
+2.75%
Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies

Teknova to Become the Exclusive Manufacturer and Distributor of Pluristyx’s Novel PluriFreeze™ Cryopreservation SystemHOLLISTER, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), and Pluristyx, Inc., today announced that the companies are collaborating to produce and commercialize Pluristyx's PluriFreeze™ product line, a cryopreservative and cell wash media system intended for use by customers who are developing next generation allogeneic cell therapies.

GlobeNewswire 2 months ago

TKNO
+2.75%
Earnings Update: Here's Why Analysts Just Lifted Their Alpha Teknova, Inc. (NASDAQ:TKNO) Price Target To US$10.67

Shareholders might have noticed that Alpha Teknova, Inc. ( NASDAQ:TKNO ) filed its yearly result this time last week...

Simply Wall St. 2 months ago

TKNO
+2.75%
Alpha Teknova: Q4 Earnings Snapshot

The Hollister, California-based company said it had a loss of 11 cents per share. The maker of reagents used by the biopharmaceutical industry posted revenue of $9.3 million in the period. For the year, the company reported a loss of $26.7 million, or 57 cents per share.

Associated Press Finance 2 months ago

TKNO
+2.75%
Teknova Reports Fourth Quarter and Full Year 2024 Financial Results

Full year 2024 total revenue was $37.7 million, up 3% year-over-year and in line with guidanceFourth quarter 2024 total revenue was $9.3 million, up 18% over the same quarter prior yearCompany provides 2025 revenue guidance of $39-42 million HOLLISTER, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova” or the “Company”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular d

GlobeNewswire 2 months ago

TKNO
+2.75%
Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

HOLLISTER, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2024, on Tuesday, March 4, 2025, following the close of market. Teknova will host a webcast and conference call on Tuesday, M

GlobeNewswire 2 months ago

TKNO
+2.75%
Here’s What Boosted Alpha Teknova (TKNO) in Q4

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. For the second consecutive year, U.S. equity indices ended the year with double-digit returns after generating modest returns in the fourth quarter of 2024. Conestoga’s investment plans were hindered by the enthusiasm for everything […]

Insider Monkey 3 months ago

TKNO
+2.75%

^RUT
Positive Signs As Multiple Insiders Buy Alpha Teknova Stock

When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...

Simply Wall St. 3 months ago

TKNO
+2.75%
Alpha Teknova Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Alpha Teknova ( NASDAQ:TKNO ) Third Quarter 2024 Results Key Financial Results Revenue: US$9.58m (up 17% from 3Q 2023...

Simply Wall St. 6 months ago

TKNO
+2.75%
Alpha Teknova: Q3 Earnings Snapshot

TKNO) on Thursday reported a loss of $7.6 million in its third quarter. On a per-share basis, the Hollister, California-based company said it had a loss of 15 cents. The maker of reagents used by the biopharmaceutical industry posted revenue of $9.6 million in the period.

Associated Press Finance 6 months ago

TKNO
+2.75%
Teknova Reports Third Quarter 2024 Financial Results

Third quarter 2024 total revenue was $9.6 million, up 17% over the same quarter prior yearCompany lowers 2024 total free cash outflow outlook to less than $16 millionCompany reaffirms 2024 revenue guidance of $35-38 million HOLLISTER, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova” or the “Company”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today a

GlobeNewswire 6 months ago

TKNO
+2.75%
Teknova to Report Third Quarter 2024 Financial Results on November 7, 2024

HOLLISTER, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the third quarter ended September 30, 2024, on Thursday, November 7, 2024, following the close of market. Teknova will host a webcast and conference call on Thursday, November 7

GlobeNewswire 6 months ago

TKNO
+2.75%
Several Factors Lifted Alpha Teknova (TKNO) in Q3

Conestoga Capital Advisors, an asset management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. At its September meeting, the Federal Reserve lowered the Federal Funds rate by 50 basis points due to weaker employment growth and moderate inflation. Equity markets welcomed the news, raising optimism for a soft landing in […]

Insider Monkey 6 months ago

TKNO
+2.75%

^RUT
What Makes Alpha Teknova (TKNO) a Strong Momentum Stock: Buy Now?

Does Alpha Teknova (TKNO) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks 6 months ago

TKNO
+2.75%

Performance Overview

Return	TKNO	S&P 500 (^GSPC)
YTD	-19.52%	+1.00%
1-Year	+275.42%	+11.91%
3-Year	-29.63%	+52.27%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Alpha Teknova, Inc. (TKNO)

Sidoti Events, LLC's Virtual May Micro-Cap Conference

Alpha Teknova Inc (TKNO) Q1 2025 Earnings Call Highlights: Revenue Growth Amidst Challenges

Alpha Teknova: Q1 Earnings Snapshot

Teknova Reports First Quarter 2025 Financial Results

Alpha Teknova (TKNO) Traded Lower on Increased Uncertainty

Teknova to Report First Quarter 2025 Financial Results on May 8, 2025

Teknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell Therapies

Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies

Earnings Update: Here's Why Analysts Just Lifted Their Alpha Teknova, Inc. (NASDAQ:TKNO) Price Target To US$10.67

Alpha Teknova: Q4 Earnings Snapshot

Teknova Reports Fourth Quarter and Full Year 2024 Financial Results

Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

Here’s What Boosted Alpha Teknova (TKNO) in Q4

Positive Signs As Multiple Insiders Buy Alpha Teknova Stock

Alpha Teknova Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Alpha Teknova: Q3 Earnings Snapshot

Teknova Reports Third Quarter 2024 Financial Results

Teknova to Report Third Quarter 2024 Financial Results on November 7, 2024

Several Factors Lifted Alpha Teknova (TKNO) in Q3

What Makes Alpha Teknova (TKNO) a Strong Momentum Stock: Buy Now?

Performance Overview